Adam Burns

Medicine · Health Sciences

15h-index1.3kcitations58works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(34), Lymphoma Diagnosis and Treatment(16), Cancer Genomics and Diagnostics(13), Immunodeficiency and Autoimmune Disorders(10), Glycosylation and Glycoproteins Research(9)

Publications58 total

Is liquid biopsy a cost-effective method to diagnose Burkitt Lymphoma in children and young adults? A health economic evaluation in Tanzania
BMC Medicine·2026Open Access
Evidence of latent-lytic replication in EBV-positive Burkitt lymphoma from whole genome and transcriptome sequencing
2025Open Access
Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma
2025Open Access
Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumor DNA: A Comparative Microcosting Study
Value in Health Regional Issues·2025· 1 citedOpen Access
Targeted Next-Generation Sequencing of Cell-Free DNA to Detect <i>MYC</i> -Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa
JCO Global Oncology·2025· 2 citedOpen Access
Genomic Landscape of Epstein-Barr Virus in Endemic Burkitt Lymphoma
Blood·2023· 2 cited
Performance of a Liquid Biopsy Diagnostic Prediction Model for EBV-Positive Burkitt Lymphoma in Sub-Saharan Africa
Blood·2023Open Access
LIQUID BIOPSY FOR EARLY, NON‐INVASIVE DIAGNOSIS OF EBV‐POSITIVE BURKITT LYMPHOMA IN RESOURCE LIMITED SETTINGS
Hematological Oncology·2023Open Access
Supplementary Data from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
2023Open Access
Data from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
2023Open Access
Supplementary Data Tables from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
2023Open Access
Supplementary Data Tables from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
2023Open Access
Data from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
2023Open Access
Supplementary Data from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
2023Open Access
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features
Nature Genetics·2022· 70 citedOpen Access
Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania
BMC Genomics·2021· 10 citedOpen Access
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes
Gastroenterology·2021· 44 citedOpen Access
TET2 drives 5hmc marking of <i>GATA6</i> and epigenetically defines pancreatic ductal adenocarcinoma transcriptional subtypes
2020· 2 citedOpen Access
Comprehensive genomic testing for chronic lymphocytic leukaemia patients: WGS, one key to patient stratification
Leukemia & lymphoma/Leukemia and lymphoma·2020
Abstract PR02: Loss of TET2 activity results in epigenetic instability and drives PDAC molecular subtypes
Cancer Research·2019· 1 cited
page 1 of 3Next →

Frequent Co-authors

Anna Schuh(42), Ruth Clifford(24), Pauline Robbe(24), Hélène Dreau(21), Adele Timbs(20), Basile Stamatopoulos(14), Samantha J.L. Knight(13), Peter Hillmen(13), Reem Alsolami(12), Dimitris Vavoulis(12), Jenny C. Taylor(11), Kate Ridout(11), Joanne Mason(10), Andrew R. Pettitt(9), Maité Cabes(8), Heavenlight Christopher(8), Emmanuel Josephat(8), Jennifer Becq(7), Angela Hamblin(7), Jacqueline Boultwood(7)